glp 1 agonist parkinson GLP-1 Receptor Agonists: A New Treatment in Parkinson's Disease Repurposing glucagon-like peptide-1 receptor agonists
Description
What Were Seeing Usage of GLP-1 medications is soaring
(Lausanne) [DOI] [PMC free article] [PubMed] [Google Scholar] 157.Lai X., Wolkenhauer O., Vera J
L.PierceR
This can influence several cellular functions, including insulin secretion in pancreatic islet cells, as depicted in the schematic
Agcakaya E, Mutlu HH, Erbakan A, Sargin M
All authors reviewed and revised the manuscript
